Executive VP of LabStyle Innovations Discusses Firm's Innovative Blood Glucose Testing Technology and His Firm's Current Value Proposition
- 54
LOS ANGELES, CA / ACCESSWIRE / September 24, 2015 / BioMedReports editor, M.E. Garza recently met with LabStyle Innovations Corp. (OTCQB: DRIO), new Executive Vice President and General Manager of US sales, Todd Durniak to discuss the company's innovative Dario(TM) Diabetes Management Solution, which offers people with diabetes an opportunity to turn an iPhone or Android phone into a cloud-linked blood glucose management system.
Find out why investors should be paying attention to this emerging technology company right now.
The complete interview with CEO, Todd Durniak is available now at: http://www.biomedreports.com/20150924237569/qaa-with-labstyle-innovations-exec-vp-todd-durniak.html
Healthcare investors and Biotech traders interested in accessing BioMedReports' new complete database of clinical trials and upcoming FDA and world-wide regulatory decisions which can be used to make more profitable trades and see upcoming catalysts can go to: http://biomedreports.com/fdacal.html.
About BioMedReports
BioMedReports is a news and research portal covering financial biotech news for the entire Healthcare Sector of the market. Full disclosures and information about the stocks and information mentioned in this news release are available at BioMedReports.com.
Media contact: Jackie Rodriguez 646-430-5783
SOURCE: BioMedReports
ACCESSWIRE is a premier news and communications network, providing regional, national, and global news to hundreds of clients globally. In addition to our world class and ever growing distribution network, ACCESSWIRE is also leading the way in social engagement, targeting and analytics.
